Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Redox-sensitive signaling proteins are a broad class of proteins whose functions are modulated by reversible oxidative modifications, typically occurring at specific cysteine residues [1.1.1, 1.4.1]. These proteins serve as critical sensors and transducers of cellular redox status, converting chemical signals from reactive oxygen species (ROS) into biological responses [1.1.2, 1.5.1]. Key members of this group include transcription factors like Nrf2 and NF-κB, kinases such as p38 MAPK and JNK, and various phosphatases like PTP1B and PTEN [1.1.3, 1.3.1]. Under physiological conditions, these proteins maintain redox homeostasis and regulate processes such as cell proliferation, differentiation, and apoptosis [1.1.1, 1.3.2]. However, their dysregulation is implicated in numerous pathologies, including cancer, where they often promote survival and resistance to therapy, and neurodegenerative diseases characterized by chronic oxidative stress [1.2.1, 1.3.2]. Therapeutic targeting of these proteins involves either activating cytoprotective pathways, such as the Nrf2-mediated antioxidant response, or inhibiting redox-dependent survival signals in diseased cells [1.2.1, 1.3.2]. Current drug candidates include Nrf2 activators like bardoxolone methyl and thioredoxin inhibitors like PX-12 [1.2.1, 1.2.5]. A major challenge in this field is achieving specificity to avoid interfering with essential physiological redox signaling while effectively modulating the disease-associated redox environment [1.3.2, 1.5.1].
Modulation of cysteine thiol groups through oxidation or reduction [1.1.1, 1.4.1], activation of the Nrf2-mediated antioxidant response pathway [1.3.2], inhibition of pro-inflammatory NF-κB signaling [1.3.2], scavenging of reactive oxygen species [1.2.2], and targeted inhibition of redox-regulating enzymes like thioredoxin reductase [1.2.4].
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Redox-sensitive signaling proteins.